BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green CJ, Maclure M, Fortin PM, Ramsay CR, Aaserud M, Bardal S. Pharmaceutical policies: effects of restrictions on reimbursement. Cochrane Database Syst Rev 2010;:CD008654. [PMID: 20687098 DOI: 10.1002/14651858.CD008654] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gray AL, Suleman F. The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries. Int J Clin Pharm 2015;37:717-25. [PMID: 26177819 DOI: 10.1007/s11096-015-0156-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
2 Pantoja T, Peñaloza B, Cid C, Herrera CA, Ramsay CR, Hudson J. Pharmaceutical policies: effects of regulating drug insurance schemes. Cochrane Database Syst Rev 2022;5:CD011703. [PMID: 35502614 DOI: 10.1002/14651858.CD011703.pub2] [Reference Citation Analysis]
3 Perehudoff K, Demchenko I, Alexandrov NV, Brutsaert D, Ackon A, Durán CE, El-Dahiyat F, Hafidz F, Haque R, Hussain R, Salenga R, Suleman F, Babar ZU. Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries. Int J Environ Res Public Health 2020;17:E9524. [PMID: 33353250 DOI: 10.3390/ijerph17249524] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Suh HS, Kim JA, Lee IH. Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database study. BMC Health Serv Res 2018;18:429. [PMID: 29879966 DOI: 10.1186/s12913-018-3255-y] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Herrera CA, Lewin S, Paulsen E, Ciapponi A, Opiyo N, Pantoja T, Rada G, Wiysonge CS, Bastías G, Garcia Marti S, Okwundu CI, Peñaloza B, Oxman AD. Governance arrangements for health systems in low-income countries: an overview of systematic reviews. Cochrane Database Syst Rev 2017;9:CD011085. [PMID: 28895125 DOI: 10.1002/14651858.CD011085.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
6 Flinterman LE, Hek K, Korevaar JC, van Dijk L. Impact of a Restriction in Reimbursement on Proton Pump Inhibitors in Patients with an Increased Risk of Gastric Complications. Front Public Health 2018;6:51. [PMID: 29536002 DOI: 10.3389/fpubh.2018.00051] [Reference Citation Analysis]
7 Yoo KB, Lee SG, Park S, Kim TH, Ahn J, Cho MH, Park EC. Effects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea. BMJ Open 2015;5:e006940. [PMID: 26179644 DOI: 10.1136/bmjopen-2014-006940] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
8 Hoebert JM, Souverein PC, Mantel-Teeuwisse AK, Leufkens HG, van Dijk L. Reimbursement restriction and moderate decrease in benzodiazepine use in general practice. Ann Fam Med 2012;10:42-9. [PMID: 22230829 DOI: 10.1370/afm.1319] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
9 Suleman F, Movik E. Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers. Cochrane Database Syst Rev 2019;2019. [PMID: 31721159 DOI: 10.1002/14651858.CD013478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Vicentini M, Mancuso P, Giorgi Rossi P, Di Pede S, Pellati M, Gandolfi A, Zoboli D, Riccò D, Busani C, Ferretti A. A cluster randomized trial to measure the impact on nonsteroidal anti-inflammatory drug and proton pump inhibitor prescribing in Italy of distributing cost-free paracetamol to osteoarthritic patients. BMC Fam Pract 2019;20:169. [PMID: 31810456 DOI: 10.1186/s12875-019-1050-4] [Reference Citation Analysis]
11 Bandong AN, Leaver A, Mackey M, Ingram R, Shearman S, Chan C, Cameron ID, Moloney N, Mitchell R, Doyle E, Leyten E, Rebbeck T. Adoption and use of guidelines for whiplash: an audit of insurer and health professional practice in New South Wales, Australia. BMC Health Serv Res 2018;18:622. [PMID: 30089495 DOI: 10.1186/s12913-018-3439-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Buja A, Toffanin R, Claus M, Ricciardi W, Damiani G, Baldo V, Ebell MH. Developing a new clinical governance framework for chronic diseases in primary care: an umbrella review. BMJ Open 2018;8:e020626. [PMID: 30056378 DOI: 10.1136/bmjopen-2017-020626] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
13 Moe-Byrne T, Chambers D, Harden M, McDaid C. Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review. BMJ Open 2014;4:e004623. [PMID: 24833683 DOI: 10.1136/bmjopen-2013-004623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
14 Raghavan R, Brown DS, Thompson H, Ettner SL, Clements LM, Key W. Medicaid expenditures on psychotropic medications for children in the child welfare system. J Child Adolesc Psychopharmacol 2012;22:182-9. [PMID: 22537361 DOI: 10.1089/cap.2011.0135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Smith A, Barry M. Combining health technology assessment and health technology management to deliver cost-effective prescribing and cost containment - the Irish experience. Expert Rev Pharmacoecon Outcomes Res 2020;20:431-6. [PMID: 32909850 DOI: 10.1080/14737167.2020.1822739] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Stoker LJ, Heerdink ER, Janssen R, Egberts TCG. Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis. BMJ Open 2019;9:e029148. [PMID: 31551375 DOI: 10.1136/bmjopen-2019-029148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Leopold C, Zhang F, Mantel-Teeuwisse AK, Vogler S, Valkova S, Ross-Degnan D, Wagner AK. Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses. Int J Equity Health 2014;13:53. [PMID: 25062657 DOI: 10.1186/1475-9276-13-53] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
18 Stoll M, Kollan C, Bergmann F, Bogner J, Faetkenheuer G, Fritzsche C, Hoeper K, Horst HA, van Lunzen J, Plettenberg A, Reuter S, Rockstroh J, Stellbrink HJ, Hamouda O, Bartmeyer B; ClinSurv Study Group. Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort. PLoS One 2011;6:e23946. [PMID: 21931626 DOI: 10.1371/journal.pone.0023946] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
19 Acosta A, Ciapponi A, Aaserud M, Vietto V, Austvoll-Dahlgren A, Kösters JP, Vacca C, Machado M, Diaz Ayala DH, Oxman AD. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev 2014;:CD005979. [PMID: 25318966 DOI: 10.1002/14651858.CD005979.pub2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
20 Imai S, Sundell KA, Fushimi K. Comparison of pharmaceutical policies to stimulate use of generics in Japan and Sweden. Health Policy and Technology 2016;5:189-95. [DOI: 10.1016/j.hlpt.2016.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Iskrov G, Stefanov R. Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria. Balkan Med J 2016;33:27-35. [PMID: 26966615 DOI: 10.5152/balkanmedj.2015.15185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]